Why Doctors Are Last to Know What’s in the Drug Supply
Summary
The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
Description from TIME.
Who is covering this
-
Why Doctors Are Last to Know What’s in the Drug Supply
The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
Related stories
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
6 sourcesvia The HinduTruth score 701
FDA scientists opposed Trump administration’s move to ease peptide access
4 sourcesvia The GuardianTruth score 66
Trump administration says biggest changes coming to infant formula in nearly 30 years
2 sourcesvia ABC News (US)Truth score 533
FDA issues alert about Northfield-based Medline beds tied to fire-related deaths and injuries
2 sourcesvia Chicago Sun-TimesTruth score 52
FDA again bypasses advisers to remove black-box warnings from menopause treatments
1 sourcevia The GuardianTruth score 45
Maharashtra suspends four FDA officials over hookah tobacco lapses
1 sourcevia India TodayTruth score 40